July 27 2023: MaaT Pharma Provides Second Quarter 2023 Business Update and Reports Financial Results
MaaT Pharma Provides Second Quarter 2023 Business Update and Reports Financial Results Data presented at…
MaaT PharmaJuly 27, 2023
MaaT Pharma Joins Microbiome Therapeutics Innovation Group Lyon, France, July 20, 2023 6:00 pm CET…
MaaT PharmaJuly 20, 2023
MaaT Pharma: Half-year Report on Liquidity Contract With the Brokerage Firm Kepler Cheuvreux Lyon, France,…
MaaT PharmaJuly 13, 2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaJuly 6, 2023
MaaT Pharma Announces New Appointments to the Board and Executive Team Appointments to the Board…
MaaT PharmaJune 21, 2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaJune 9, 2023
MaaT Pharma Announces Combined General Meeting on June 19, 2023 and the Availability of the Preparatory…
MaaT PharmaMay 26, 2023
MaaT Pharma Announces Cash and Revenues for the First Quarter of 2023 As of March…
MaaT PharmaMay 9, 2023
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaMay 3, 2023
